STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$32.38 USD
+2.41 (8.04%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $32.39 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$32.38 USD
+2.41 (8.04%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $32.39 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth B Momentum D VGM
Zacks News
Staar Surgical (STAA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Staar Surgical (STAA) closed the most recent trading day at $63.48, moving +1.6% from the previous trading session.
Staar Surgical (STAA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Staar Surgical (STAA) closed the most recent trading day at $61.24, moving -1.65% from the previous trading session.
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to STAAR Surgical (STAA) stock based on the movements in the options market lately.
Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Staar Surgical (STAA) delivered earnings and revenue surprises of -6.67% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Henry Schein (HSIC) Matches Q4 Earnings Estimates
by Zacks Equity Research
Henry Schein (HSIC) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Staar Surgical (STAA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Staar Surgical (STAA) closed at $69.41 in the latest trading session, marking a +1.24% move from the prior day.
Staar Surgical (STAA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Staar Surgical (STAA) closed the most recent trading day at $77.97, moving -1.73% from the previous trading session.
STAAR Surgical (STAA) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Strong growth in EVO ICL units led by increased market adoption is likely to have driven STAAR Surgical's (STAA) Q4 revenues.
STAAR Surgical Company (STAA) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Staar Surgical (STAA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Cardinal Health (CAH) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cardinal (CAH) delivered earnings and revenue surprises of 16.81% and 2.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
AmerisourceBergen (ABC) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 3.44% and 0.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Staar Surgical (STAA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Staar Surgical (STAA) closed the most recent trading day at $69.42, moving +0.78% from the previous trading session.
Staar Surgical (STAA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Staar Surgical (STAA) closed at $73.93, marking a +1.97% move from the previous day.
Why You Should Hold Elevance Health (ELV) in Your Portfolio
by Zacks Equity Research
Elevance Health (ELV) remains well-poised for growth due to a growing customer base within its Government and IngenioRx businesses coupled with solid cash-generating abilities.
Teladoc (TDOC) Unveils App to Simplify Whole-Person Care
by Zacks Equity Research
Teladoc Health (TDOC) launches a digital app that will provide a broad range of TDOC's services to cater to the whole-person health needs of members.
Here's Why You Should Hold Cigna (CI) Stock in Your Portfolio
by Zacks Equity Research
Cigna (CI) remains well-poised for growth on the back of the solid Evernorth and Cigna Healthcare businesses, an expanding customer base and robust cash-generating abilities.
Community Health (CYH) Sells Hospital, Renews Health Net Tie-Up
by Zacks Equity Research
Community Health (CYH) announces the divestiture of its West Virginia hospital and the expansion of its alliance with Health Net, thereby undertaking initiatives to boost business prospects.
New Strong Buy Stocks for January 4th
by Zacks Equity Research
STAA, CASY, THRM, MP and UTHR have been added to the Zacks Rank #1 (Strong Buy) List on January 4 , 2023.
Is the Options Market Predicting a Spike in STAAR Surgical (STAA) Stock?
by Zacks Equity Research
Investors need to pay close attention to STAAR Surgical (STAA) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in STAAR (STAA) Stock?
by Zacks Equity Research
Investors need to pay close attention to STAAR (STAA) stock based on the movements in the options market lately.
Staar Surgical (STAA) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Staar Surgical (STAA) delivered earnings and revenue surprises of 76.19% and 1.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
LabCorp (LH) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
LabCorp (LH) delivered earnings and revenue surprises of -0.64% and 5.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Reasons Why Growth Investors Shouldn't Overlook Staar Surgical (STAA)
by Zacks Equity Research
Staar Surgical (STAA) possesses solid growth attributes, which could help it handily outperform the market.
Is Staar Surgical (STAA) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Staar Surgical (STAA) could produce exceptional returns because of its solid growth attributes.
Staar Surgical (STAA) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Staar Surgical (STAA) could produce exceptional returns because of its solid growth attributes.